ÂÜÀòÂÒÂ×

Brad Greenfield is a highly experienced scientist specializing in cellular research and assay development, currently serving as Associate Director of Cellular Research and Innovation at Adaptive Biotechnologies Corp. since November 2018. Previously, Brad held positions at OncoResponse Inc. from January 2012 to November 2018, where responsibilities included leading the Assay Development and Screening Department. Earlier experiences encompass roles at Amgen, Immunex, MDS Pharma Services, Bristol Myers Squibb, Fred Hutchinson Cancer Research Center, and the Center for Infectious Disease Research. Brad's extensive background in developing screening assays and conducting immune cell functional assays is complemented by a Bachelor's degree in Biology and Chemistry from Willamette University and further education from Colorado State University.